SCHEMBL29775098

SCHEMBL29775098

C1=Nc2ccc(-c3ccnc(Nc4ccccn4)n3)cc2C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK13 O15264 1/20 0.42
▸ MAPK12 P53778 1/20 0.42
▸ MAPK11 Q15759 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ CDK4 P11802 3/20 0.42
▸ CCND1 P24385 3/20 0.42
▸ CCNA2 P20248 3/20 0.42
▸ CDK2 P24941 3/20 0.42
▸ CDK1 P06493 2/20 0.42
▸ CCNB1 P14635 2/20 0.42
▸ CCNA1 P78396 2/20 0.42
▸ KDR P35968 1/20 0.41
▸ BTK Q06187 1/20 0.40
▸ NPC1 O15118 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ ALPL P05186 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27145118 0.77 NPC1 (0.49) MAPK13MAPK12MAPK11MAPK14CDK4
SCHEMBL27148413 0.73 IGF1R (0.49) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL2819228 0.71 CDK4 (0.54) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL29557417 0.70 ABL1 (0.72) CDK4CCND1CCNA2CDK2CDK1
SCHEMBL434285 0.68 TBK1 (0.58) MAPK13MAPK12MAPK11MAPK14CCNA2
SCHEMBL2321728 0.65 CDK4 (0.52) MAPK13MAPK12MAPK11MAPK14CDK4
SCHEMBL29386286 0.65 CDK4 (0.49) MAPK13MAPK12MAPK11MAPK14CDK4
SCHEMBL20455525 0.65 CDK4 (0.49) MAPK13MAPK12MAPK11MAPK14CDK4
SCHEMBL3951276 0.65 MEN1 (0.67) KDRNPC1MEN1KMT2AGAA
SCHEMBL29544002 0.65 MEN1 (0.67) KDRNPC1MEN1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3385262-B1 4-(3H-INDOL-5-YL)-N-(PYRIDIN-2-YL)PYRIMIDIN-2-AMINE DERIVATIVES AS PROTEIN KINASE INHIBITORS, PREPARATION METHOD AND MEDICAL USE THEREOF GAN & LEE PHARMACEUTICALS (CN) 2022-07-13 — — EP disclosed
Send feedback